BrightOcular® Cosmetic Iris Implant: A Spectrum from Tolerability to Severe Morbidity
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
S. Karger AG
Abstract
Purpose: The BrightOcular® implants are the newest model of cosmetic iris devices that are currently advertised as safe. The previous generation known as NewColorIris® have had severe ocular side effects and were subsequently withdrawn from the market. There is little literature on the safety profile of BrightOcular® implants. Case Report: Herein we describe two cases with varying degrees of ocular tolerability. The first case had a normal ocular exam 1 year after implantation, whereas the second case had unilateral severe corneal edema requiring explantation of the iris device and Descemet membrane endothelial keratoplasty 9 months after bilateral implantation. Conclusions: These two cases attest to the unpredictability of the results of these cosmetic surgeries. Patients should be counseled about the vision-threatening complications of iris implants. © 2018 The Author(s).
Description
Keywords
Brightocular® iris implant, Cosmetic iris implants, Safety, Tolerability, Dexamethasone, Tobramycin, Adult, Anterior eye chamber depth, Anterior eye segment, Article, Best corrected visual acuity, Blurred vision, Case report, Caucasian, Cell density, Central corneal thickness, Clinical article, Cornea edema, Corneal pachymetry, Descemet membrane endothelial keratoplasty, Disease duration, Disease severity, Endothelium cell, Esthetic surgery, Eye refraction, Female, Follow up, Gonioscopy, Human, India, Intraocular pressure, Keratomileusis, Morbidity, Myopia, Open angle glaucoma, Ophthalmoscopy, Optical coherence tomography, Patient safety, Priority journal, Retinal nerve fiber layer thickness, Slit lamp microscopy, Surgical technique, Visual acuity, Visual field, Vitreous floaters